Cancer Vaccine Market Could Reach $8 Billion by 2012, Says New Report Available from Piribo.com

Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has just added to its collection a report on the potential market for cancer vaccines. “The Emerging Cancer Vaccine Market” http://www.piribo.com/publications/diseases_conditions/cancer/KAL029.html forecasts that the potential cancer vaccine market will grow from an estimated $481 million in 2007 to more than $8 billion by 2012.

The emergence of vaccines to both prevent and treat the escalating worldwide incidence of cancer is one of the most highly anticipated areas of pharmaceutical R&D. According to the 270 page report, a number of promising vaccines are in late stage development and are preparing for regulatory review. 2008 may see as many as five approvals, and by 2012, eight additional approvals are possible.

Many of the products with potential approval status over the coming years are already in Phase III development, have orphan drug status, SPA status, or Fast Track status.

This unique report chronicles the technological, clinical, and business trends shaping this growth field in regards to cervical, colorectal, prostate, and lung cancers, melanoma, lymphoma, and others. It includes research and development pipelines, in-depth company profiles, market forecasts and more. Each market segment provides an overview, descriptions of products available and in development, market estimates and forecasts for 2007-2012 by product, and competitive analysis of leading developers, including forecasted market share for 2012. The report also includes statistical information on cancers by type worldwide and in the United States.

“The Emerging Cancer Vaccine Market,” is available in PDF format from Piribo. For more information, go to: http://www.piribo.com/publications/diseases_conditions/cancer/KAL029.html


About Piribo.
Piribo is a UK-based independent online store supplying business information on the pharmaceutical and biotechnology industries. The website now carries over 5,500 English language titles including, market reports, studies and books and is the UK’s largest online biopharma information store. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest. The company was established in 2004.